Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9B4T

Crystal structure of the MRAS-p110alpha complex

9B4T の概要
エントリーDOI10.2210/pdb9b4t/pdb
分子名称Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform, Ras-related protein M-Ras, (2S)-2-({2-[1-(propan-2-yl)-1H-1,2,4-triazol-5-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}oxy)propanamide, ... (6 entities in total)
機能のキーワードras, rras3, mras, p110alpha, pik3ca, pi3kalpha, oncoprotein, pi3ka, pi3k
由来する生物種Homo sapiens (human)
詳細
タンパク質・核酸の鎖数2
化学式量合計133346.60
構造登録者
Czyzyk, D.J.,Simanshu, D.K. (登録日: 2024-03-21, 公開日: 2025-01-22)
主引用文献Czyzyk, D.,Yan, W.,Messing, S.,Gillette, W.,Tsuji, T.,Yamaguchi, M.,Furuzono, S.,Turner, D.M.,Esposito, D.,Nissley, D.V.,McCormick, F.,Simanshu, D.K.
Structural insights into isoform-specific RAS-PI3K alpha interactions and the role of RAS in PI3K alpha activation.
Nat Commun, 16:525-525, 2025
Cited by
PubMed Abstract: Mutations in RAS and PI3Kα are major drivers of human cancer. Their interaction plays a crucial role in activating PI3Kα and amplifying the PI3K-AKT-mTOR pathway. Disrupting RAS-PI3Kα interaction enhances survival in lung and skin cancer models and reduces tumor growth and angiogenesis, although the structural details of this interaction remain unclear. Here, we present structures of KRAS, RRAS2, and MRAS bound to the catalytic subunit (p110α) of PI3Kα, elucidating the interaction interfaces and local conformational changes upon complex formation. Structural and mutational analyses highlighted key residues in RAS and PI3Kα impacting binding affinity and revealed isoform-specific differences at the interaction interface in RAS and PI3K isoforms, providing a rationale for their differential affinities. Notably, in the RAS-p110α complex structures, RAS interaction with p110α is limited to the RAS-binding domain and does not involve the kinase domain. This study underscores the pivotal role of the RAS-PI3Kα interaction in PI3Kα activation and provides a blueprint for designing PI3Kα isoform-specific inhibitors to disrupt this interaction.
PubMed: 39788953
DOI: 10.1038/s41467-024-55766-x
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.75 Å)
構造検証レポート
Validation report summary of 9b4t
検証レポート(詳細版)ダウンロードをダウンロード

252456

件を2026-04-22に公開中

PDB statisticsPDBj update infoContact PDBjnumon